Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/09/2010CA2762375A1 Antibodies against human ccn1 and uses thereof
12/09/2010CA2762342A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine
12/09/2010CA2761959A1 Conjugation methods
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/09/2010CA2757083A1 Amino pyrimidine anticancer compounds
12/08/2010EP2258865A1 Lysine-specific demethylase 1 (LSD1) is a biomarker for breast cancer
12/08/2010EP2258849A1 Mammalian receptor proteins; related reagents and methods
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258724A1 Modulating immune responses using multimerized anti-CD83 antibodies
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258720A1 Multiple target T cell receptor
12/08/2010EP2258719A1 Multiple target T cell receptor
12/08/2010EP2258715A1 Kahalalide compounds
12/08/2010EP2258712A2 Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
12/08/2010EP2258704A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
12/08/2010EP2258702A2 Purified compositions of 10-Propargyl-10-Deazaaminopterin and method of using same in the treatment of tumors
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258699A1 Polymorphs of a pyrrole-substituted 2-Indolinone protein kinase inhibitor
12/08/2010EP2258698A2 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258415A2 Medical devices containing rapamycin analogs
12/08/2010EP2258397A1 Polymer conjugate of physiologically active substance
12/08/2010EP2258393A1 Abc transporter protein expression inhibitor
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2258383A2 Antigenic peptides derived from telomerase
12/08/2010EP2258378A1 Anti-tumor agent comprising cytidine derivative and carboplatin
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
12/08/2010EP2258371A1 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
12/08/2010EP2258370A1 Treatment of malignant diseases
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2257626A2 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
12/08/2010EP2257572A1 Human anti-mesothelin monoclonal antibodies
12/08/2010EP2257558A1 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation
12/08/2010EP2257554A1 Tricyclic benzoý4,5¨thieno-ý2,3-d¨pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
12/08/2010EP2257547A1 Novel benzimidazole linked pyrroloý2,1-qý1,4¨benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
12/08/2010EP2257544A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
12/08/2010EP2257316A2 Contrast agents, methods for preparing contrast agents, and methods of imaging
12/08/2010EP2257312A2 Nanoparticles for targeted delivery of active agents to the lung
12/08/2010EP2257309A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
12/08/2010EP2257303A1 Uses of modified elr-cxc chemokine g31p
12/08/2010EP2257293A2 Combination therapy with c-met and egfr antagonists
12/08/2010EP2257177A1 New extracts of deschampsia antarctica desv. with antineoplastic activity
12/08/2010EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/08/2010EP1846373B1 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
12/08/2010EP1786925B1 Genes and polypeptides relating to breast cancers
12/08/2010EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof
12/08/2010EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
12/08/2010EP1572726B1 4-methylhexanoic kahalalide f compound
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1496109B1 Process for producing cytotoxic lymphocyte
12/08/2010EP1494693B1 Cripto-specific antibodies
12/08/2010EP1481095B1 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/08/2010EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP1082341B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1960733B Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor
12/08/2010CN1948333B New hPEBP4 protein source HLA-A2 limiting epi-polypeptide and its application
12/08/2010CN1882570B Quinazoline derivatives
12/08/2010CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine
12/08/2010CN1759118B Diazepinoindole derivatives as kinase inhibitors
12/08/2010CN1709409B Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1660184B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101910182A Antitumor agent
12/08/2010CN101910176A Derivatives of N-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910175A N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
12/08/2010CN101910174A 2-benzoylimidazo[1,2-a]pyridine derivates, preparation thereof and therapeutic use thereof
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910168A Tropane compounds
12/08/2010CN101910167A Heterocyclic ether and thioether derivatives and methods of use thereof
12/08/2010CN101910165A Thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910164A Diamido thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910163A Heterocyclic urea and thiourea derivatives and methods of use thereof
12/08/2010CN101910158A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910149A Pyridazine fungicides
12/08/2010CN101909693A Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases
12/08/2010CN101909639A Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
12/08/2010CN101909633A Use of a gamma-secretase inhibitor for treating cancer
12/08/2010CN101909630A Methods and compounds for preventing and treating a tumour
12/08/2010CN101909624A Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives
12/08/2010CN101909622A Pyrrolo [1,2-C] imidazole derivates for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
12/08/2010CN101909619A Composition comprising sesamin component and quercetin glycoside
12/08/2010CN101909613A Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
12/08/2010CN101909602A Oral powder and granular antitumor agent
12/08/2010CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same
12/08/2010CN101906431A Expression vector of introne small interfering RNA, construction method and application thereof
12/08/2010CN101906173A Method for preparing mycelium polysaccharides by using biological enzyme
12/08/2010CN101906172A Method for extracting water-insoluble polysaccharide of mushroom by enzyme process
12/08/2010CN101906164A Coupled protein
12/08/2010CN101906148A Survivin-derived peptides and use thereof
1 ... 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 ... 2211